VistaGen Therapeutics to Present at Two Investor Conferences in June
May 20 2021 - 8:00AM
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company
committed to developing new generation medicines with the potential
to go beyond the current standard of care for anxiety, depression,
and other central nervous system (“CNS”) disorders, today announced
that it will present at the following investor conferences in June:
Jefferies
Virtual Healthcare Conference |
Date: |
Wednesday, June 2nd at 2:30 p.m. ET |
Webcast: |
https://wsw.com/webcast/jeff174/vtgn/1876041 |
Registration: |
To attend the virtual conference, please contact your Jefferies
representative. |
William
Blair 41st Annual Virtual Growth Stock Conference |
Date: |
Thursday, June 3rd at 3:00 p.m. ET |
Webcast: |
https://wsw.com/webcast/blair58/vtgn/1959945 |
Registration: |
To attend the virtual conference, please contact your William Blair
representative. |
For more information regarding these investor conferences,
please visit the sponsor’s conference website.
About VistaGenVistaGen Therapeutics is a
biopharmaceutical company committed to developing and
commercializing innovative medicines with the potential to go
beyond the current standard of care for anxiety, depression, and
other CNS disorders. Each of VistaGen's drug candidates has a
differentiated potential mechanism of action, has been
well-tolerated in all clinical studies to date, and has therapeutic
potential in multiple CNS markets. For more information, please
visit www.vistagen.com and connect with VistaGen on Twitter,
LinkedIn, and Facebook.
Company ContactsMark A. McPartland / Mark
FlatherVistaGen Therapeutics, Inc.Phone: +1 (650)
577-3600Email: IR@vistagen.com
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Apr 2023 to Apr 2024